CN103698505B - 一种高效稳定的tmb显色液及其制备方法 - Google Patents
一种高效稳定的tmb显色液及其制备方法 Download PDFInfo
- Publication number
- CN103698505B CN103698505B CN201310682191.XA CN201310682191A CN103698505B CN 103698505 B CN103698505 B CN 103698505B CN 201310682191 A CN201310682191 A CN 201310682191A CN 103698505 B CN103698505 B CN 103698505B
- Authority
- CN
- China
- Prior art keywords
- tmb
- molar concentration
- volumetric molar
- color
- nitrite ion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 7
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 title abstract 2
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims abstract description 10
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims abstract description 7
- 239000001632 sodium acetate Substances 0.000 claims abstract description 7
- 235000017281 sodium acetate Nutrition 0.000 claims abstract description 7
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 34
- 229940005654 nitrite ion Drugs 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 13
- 239000002736 nonionic surfactant Substances 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract 1
- 239000011975 tartaric acid Substances 0.000 abstract 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 51
- 238000002965 ELISA Methods 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 229920004896 Triton X-405 Polymers 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 101710132601 Capsid protein Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000003593 chromogenic compound Substances 0.000 description 2
- 239000012916 chromogenic reagent Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 108700039791 Hepatitis C virus nucleocapsid Proteins 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
- G01N2333/186—Hepatitis C; Hepatitis NANB
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
市场上TMB 显色液存在稳定性差，保存时间短，显色背景高，灵敏度低等的缺点，本发明提供了一种高效稳定的TMB显色液。其特征在于，各组分的摩尔浓度或质量分数为：TMB的摩尔浓度为1.2mmol/L，H2O2的摩尔浓度为3.1mmol/L，曲拉通X-405的质量分数为0.3%，过氧化脲的质量分数为0.5%，醋酸钠的摩尔浓度为0.2mol/L，L(+)-酒石酸的摩尔浓度为0.027 mol/L。本发明为TMB单相显色液，使用前无需混合，可以减少人为操作过程中的误差，通过引入非离子表面活性剂，使单相TMB显色液可以长期稳定保存。
Description
技术领域
本发明涉及临床体外检测技术，特别涉及一种高效稳定的TMB显色液及其制备方法。
背景技术
自从Engvall和Perlman(1971）首次报道建立酶联免疫吸附试验（Enzyme-Linked Immunosorbent Assays,ELISA）以来，由于ELISA具有快速、敏感、简便、易于标准化等优点，使其得到迅速的发展和广泛应用。目前酶免疫分析(EIA)技术，已被广泛应用于抗原，半抗原或抗体的定量或定性检测分析。酶联免疫吸附 (ELISA) 检测方法虽然有很多种，但各种方法都离不开酶结合物和显色剂。在 ELISA 试剂中应用最广泛的酶是辣根过氧化物酶 (HRP)，而该系统的显色剂有多种，目前市场最常用的是TMB （3,3’,5,5’- 四甲基联苯胺）。辣根过氧化物酶(HRP)及其藕联物是酶联免疫分析技术中常用的一种酶，由于3,3',5,5'-四甲基联苯胺(TMB)在HRP的显色反应体系中，比其它色原具有更高的灵敏度且无至癌性而被广泛应用。
TMB（3,3’,5,5’-四甲基联苯胺）是一种新型HRP（辣根过氧化物酶）色原底物。相对其他显色底物，TMB 以显色高效、无毒、不致癌、稳定性好等特点成为 ELISA 检测的主流显色剂。在ELISA检测时，HRP催化过氧化物释放出氧使 TMB 被氧化成蓝色的产物，加入酸性的终止液终止反应后，蓝色溶液变成橙黄色，在 450nm 波长有最大吸收峰。通过测量吸光度，便可定性或定量判断出被检测物的含量。
常见的 TMB 显色试剂多由几个组分共同组成，并且常需要现配现用，使用不便，且容易导致检测结果不太稳定。一般市场常见 TMB 显色试剂通常分为 A、B 两种贮存液，使用需将两者按比例混合，操作繁琐且容易错配，常导致实验失败。此外，市场上也有少见的单相的TMB 显色液，但常常存在稳定性差，保存时间短，显色背景高，灵敏度低等的缺点。
发明内容
针对上述技术背景，本发明提供了一种高效稳定的TMB显色液及其制备方法。
本发明的一种高效稳定的TMB显色液，其特征在于，各组分的摩尔浓度或质量分数为：TMB的摩尔浓度为1.2mmol/L，H2O2的摩尔浓度为3.1mmol/L，曲拉通X-405的质量分数为0.3%，过氧化脲的质量分数为0.5%，醋酸钠的摩尔浓度为0.2mol/L，L(+)-酒石酸的摩尔浓度为0.027 mol/L。
所述的一种高效稳定的TMB显色液的制备方法，其特征在于包括以下步骤：
a.制备A液：以10mL二甲亚砜为溶剂，缓慢加入TMB，搅拌均匀使其充分溶解，TMB最终摩尔浓度为0.12mol／L；
b.制备B液：取1L蒸馏水，加入醋酸钠16.406g使之终摩尔浓度为0.2mol/L；然后加入L(+)-酒石酸4.1g使之终摩尔浓度为0.027 mol/L，溶液最终pH值约为5.0。
c.在B液中加入适量A液、曲拉通X-405（Triton X-405）、H2O2和过氧化脲，使TMB终摩尔浓度为1.2 mmol/L，H2O2终摩尔浓度为3.1mmol/L，曲拉通X-405（Triton X-405）的终质量分数为0.3%，过氧化脲的终质量分数为0.5%。
本发明的使用方法：
用适当的干净容器(用纯净水反复冲洗)，倒出适量的单组分TMB显色液，待达到室温后即可进行如下步骤：
a) 加液：加完HRP结合物并温育一定时间后，洗板3-5次，每孔加TMB显色液100uL。 根据实验需要，在室温(15-25°C)或37°C下温育10-30分钟。
b) 终止：加等体积的1mol／L盐酸或硫酸溶液可终止反应，孔中反应液由蓝色变为黄色。
c) 读数：终止反应后30分钟内在450nm处读数。
相比市场常见TMB显色液而言，本发明为TMB单相显色液，使用前无需混合，简化操作流程，方便快捷，可以减少人为操作过程中的误差。通过引入非离子表面活性剂，促进TMB的溶解和稳定，使单相TMB显色液可以长期稳定保存，在2~8℃条件下保存有效期可达3年，并且显色终止后读数稳定。
附图说明
下面结合附图对本发明的具体实施方式作进一步详细的说明。
图1 实施例1方法制备的TMB显色液用酸溶液终止反应后TMB黄色产物的稳定性。
图2 实施例1方法制备的TMB显色液存放时间段后的稳定性。
具体实施方式
实施例1
本发明所述的一种高效稳定的TMB 显色液的制备方法包括如下步骤：
a制备A液：以10mL二甲亚砜为溶剂，缓慢加入TMB，搅拌均匀使其充分溶解，TMB最终摩尔浓度为0.12mol／L；
b.制备B液：取1L蒸馏水，加入醋酸钠16.406g充分溶解，使之终摩尔浓度为0.2mol/L；然后加入L(+)-酒石酸（L(+)-2,3-二羟基丁二酸）4.1g充分溶解，使之终摩尔浓度为0.027 mol/L， 溶液最终pH值约为5.0。
c.在B液中加入适量A液、曲拉通X-405（Triton X-405）、H2O2和过氧化脲，使TMB终摩尔浓度为1.2 mmol/L，H2O2终摩尔浓度为3.1mmol/L，曲拉通X-405（Triton X-405）的终质量分数为0.3%，过氧化脲的终质量分数为0.5%，醋酸钠的摩尔浓度为0.2mol/L，L(+)-酒石酸的摩尔浓度为0.027 mol/L。
实施例2
将实施例1的TMB显色液与国家食品药品监督管理局认可的某公司商品化的TMB显色液（简称为：对比显色液1）进行对比。
该对比显色液配方，其中各组分的摩尔浓度或质量分数为：
TMB的摩尔浓度为2.0mmol/L，
H2O2的摩尔浓度为4.0mmol/L，
过氧化脲的质量分数为0.1%，
磷酸氢二钠的摩尔浓度为0.1mol/L，
柠檬酸的摩尔浓度为0.013 mol/L。
以丙型肝炎病毒核心抗原试剂盒（双抗体夹心法ELISA）为例，显色15min后终止反应，在终止反应后的0，15，30，45，60min时测得OD值（λ=450nm）。用酸溶液终止反应后，计算TMB黄色产物的稳定性。
对比结果见说明书附图图1。由图1可以看出，实施例1方法得到的TMB显色液在终止反应后，TMB黄色产物的稳定性明显优于对比组TMB显色液。实施例1方法得到的TMB显色液在终止反应30分钟后，TMB换色产物几乎没有衰减；在终止反应60min时，仅有轻微衰减，稳定性明显提高。
实施例3
将用实施例1的方法制备的TMB显色液与国家食品药品监督管理局认可的某公司商品化的TMB显色液进行比较（简称为：对比显色液1）。
以丙型肝炎病毒核心抗原试剂盒（双抗体夹心法ELISA）为例，分别用实施例1的方法制备的TMB显色液和国家食品药品监督管理局认可的某公司商品化的TMB显色液（简称为：对比显色液1）做显色剂，测试丙肝核心抗原（HCV-cAg）标准品（浓度：80pg/mL），测试完成后试剂盒等均放置在2-8℃保存，每隔2个月测试一次，记录OD值。 对比结果见说明书附图图2。由图2可知，实施例1的方法制备的TMB显色液可以长期稳定存放，至少可以放置3年。
由此可见，相比市场常见TMB显色液而言，本发明为TMB单相显色液，使用时无需混合，简化操作流程，方便快捷，极大的减少人为操作误差。此外，通过加入非离子表面活性剂曲拉通X-405（Triton X-405），促进TMB的溶解和稳定，使单相TMB显色液可以长期稳定保存，在2~8℃条件下有效期3年，并且显色终止后读数稳定。可证明，本发明所涉及的TMB显色液具有高效稳定的特点，使用方便，可以满足酶联免疫试剂盒对显色底物液的各项要求。
Claims (2)
1.一种高效稳定的TMB显色液，其特征在于，各组分的摩尔浓度或质量分数为：TMB的摩尔浓度为1.2mmol/L，H2O2的摩尔浓度为3.1mmol/L，曲拉通X-405的质量分数为0.3%，过氧化脲的质量分数为0.5%，醋酸钠的摩尔浓度为0.2mol/L，L(+)-酒石酸的摩尔浓度为0.027 mol/L。
2.根据权利要求1中的一种高效稳定的TMB显色液的制备方法，其特征在于包括以下步骤：
a.制备A液：以10mL二甲亚砜为溶剂，缓慢加入TMB，搅拌均匀使其充分溶解，TMB最终摩尔浓度为0.12mol／L；
b.制备B液：取1L蒸馏水，加入醋酸钠16.406g充分溶解，使之终摩尔浓度为0.2mol/L；然后加入L(+)-酒石酸4.1g充分溶解，使之终摩尔浓度为0.027 mol/L， 溶液最终pH值约为5.0；
c.在B液中加入适量A液、曲拉通X-405、H2O2和过氧化脲，使TMB终摩尔浓度为1.2 mmol/L，H2O2终摩尔浓度为3.1mmol/L，曲拉通X-405的终质量分数为0.3%，过氧化脲的终质量分数为0.5%。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310682191.XA CN103698505B (zh) | 2013-12-13 | 2013-12-13 | 一种高效稳定的tmb显色液及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310682191.XA CN103698505B (zh) | 2013-12-13 | 2013-12-13 | 一种高效稳定的tmb显色液及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103698505A CN103698505A (zh) | 2014-04-02 |
| CN103698505B true CN103698505B (zh) | 2015-06-10 |
Family
ID=50360104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310682191.XA Active CN103698505B (zh) | 2013-12-13 | 2013-12-13 | 一种高效稳定的tmb显色液及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103698505B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104459109B (zh) * | 2014-11-25 | 2016-03-23 | 成都威尔诺生物科技有限公司 | 一种用于酶联免疫反应的单组份tmb显色液 |
| CN106153907A (zh) * | 2015-03-25 | 2016-11-23 | 霍普金斯(北京)医学诊断科技有限公司 | 一种基于胶体金的酶联免疫显色试剂 |
| CN105116141B (zh) * | 2015-07-02 | 2016-09-14 | 深圳市卫光生物制品股份有限公司 | 一种单组份tmb显色液及其制备方法 |
| CN107190050B (zh) * | 2016-03-14 | 2020-10-27 | 华东理工大学 | 一种hrp活性测定及h2o2浓度检测的试剂盒及其应用 |
| CN105974107B (zh) * | 2016-07-13 | 2018-01-30 | 广州捷倍斯生物科技有限公司 | 单组份tmb显色液及其配制方法 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19813158C2 (de) * | 1998-03-19 | 2002-06-06 | Seramun Diagnostica Gmbh | Stabile TMB-/Substratlösungen |
| EP1000358B1 (en) * | 1997-07-15 | 2003-04-02 | Kem-En-Tec A/S | Pre-stained 3,3',5,5'-tetramethylbenzidine substrates for the detection of enzyme activity |
| CN101354354A (zh) * | 2007-07-23 | 2009-01-28 | 深圳市生科源技术有限公司 | 一种过氧化物酶测定用显色液体系及其制备方法 |
| CN102435598A (zh) * | 2011-09-06 | 2012-05-02 | 山东博科生物产业有限公司 | 一种稳定的hrp酶促化学发光底物液 |
| CN102866249A (zh) * | 2012-08-15 | 2013-01-09 | 华北制药集团新药研究开发有限责任公司 | Tmb显色体系 |
| CN103063661A (zh) * | 2012-12-21 | 2013-04-24 | 杭州茂天赛科技有限公司 | 一种tmb显色液及其制备方法 |
-
2013
- 2013-12-13 CN CN201310682191.XA patent/CN103698505B/zh active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1000358B1 (en) * | 1997-07-15 | 2003-04-02 | Kem-En-Tec A/S | Pre-stained 3,3',5,5'-tetramethylbenzidine substrates for the detection of enzyme activity |
| DE19813158C2 (de) * | 1998-03-19 | 2002-06-06 | Seramun Diagnostica Gmbh | Stabile TMB-/Substratlösungen |
| CN101354354A (zh) * | 2007-07-23 | 2009-01-28 | 深圳市生科源技术有限公司 | 一种过氧化物酶测定用显色液体系及其制备方法 |
| CN102435598A (zh) * | 2011-09-06 | 2012-05-02 | 山东博科生物产业有限公司 | 一种稳定的hrp酶促化学发光底物液 |
| CN102866249A (zh) * | 2012-08-15 | 2013-01-09 | 华北制药集团新药研究开发有限责任公司 | Tmb显色体系 |
| CN103063661A (zh) * | 2012-12-21 | 2013-04-24 | 杭州茂天赛科技有限公司 | 一种tmb显色液及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103698505A (zh) | 2014-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103698505B (zh) | 一种高效稳定的tmb显色液及其制备方法 | |
| CN105388146B (zh) | 一种同时检测尿液中钠、肌酐和微量白蛋白的试剂盒 | |
| CN103063661B (zh) | 一种tmb显色液及其制备方法 | |
| CN102998445B (zh) | 一种测定甘胆酸的试剂及制备方法 | |
| CN105116141B (zh) | 一种单组份tmb显色液及其制备方法 | |
| CN105334211B (zh) | 一种同时检测尿液中钠和肌酐的试剂盒 | |
| CN105441065B (zh) | 检测次氯酸根离子的荧光探针及其制备方法与使用方法 | |
| CN105974107A (zh) | 单组份tmb显色液及其配制方法 | |
| CN103048282B (zh) | 一种胆红素的检测方法及检测试剂盒 | |
| CN102980856B (zh) | 一种羧甲基纤维素酶活力的测定方法 | |
| CN101358230A (zh) | 一种羧甲基纤维素酶活力的测定方法 | |
| CN104673878B (zh) | 一种单体系测定糖化白蛋白与白蛋白浓度比值的试剂盒 | |
| CN104195222A (zh) | 一种用于总胆固醇测定试剂盒的复合稳定剂 | |
| CN109212193A (zh) | 用于临床检测异常凝血酶原的试剂盒 | |
| CN114544973B (zh) | 试剂盒及其制备方法和应用 | |
| CN116087373A (zh) | 红细胞中叶酸和5-甲基四氢叶酸的检测方法及前处理方法 | |
| CN105021543A (zh) | 一种α-淀粉酶检测试剂及其应用 | |
| CN114441516A (zh) | 一种尿酸检测试剂盒及其制备方法 | |
| CN115894682A (zh) | 一种血清中检测tem1蛋白的方法及应用 | |
| CN101101294B (zh) | 酶联免疫体外诊断试剂中显色剂的制备 | |
| CN117929731A (zh) | 一种基质金属蛋白酶3化学发光检测试剂盒及其制备方法 | |
| CN101101295B (zh) | 酶联免疫体外诊断试剂中酶结合物溶液的制备 | |
| JP6055236B2 (ja) | 測定方法 | |
| CN111175508A (zh) | 补体c1抑制剂的检测试剂盒制备方法 | |
| CN117783541B (zh) | 一种定向偶联的胱抑素c测定试剂盒及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ma Wanshan Inventor after: Li Zhiming Inventor after: Gan Yiwu Inventor after: Tan Baiqing Inventor after: Li Jing Inventor after: Wang Qi Inventor before: Tan Baiqing Inventor before: Li Zhiming Inventor before: Gan Yiwu |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: TAN BAIQING LI ZHIMING GAN YIWU TO: MA WANSHAN LI ZHIMING GAN YIWU TAN BAIQING LI JING WANG QI |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: An efficient and stable TMB color developing solution and its preparation method Effective date of registration: 20211101 Granted publication date: 20150610 Pledgee: Overpass Branch of Jinan Rural Commercial Bank Co.,Ltd. Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2021370000122 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220624 Granted publication date: 20150610 Pledgee: Overpass Branch of Jinan Rural Commercial Bank Co.,Ltd. Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2021370000122 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A highly efficient and stable TMB color solution and its preparation method Effective date of registration: 20230206 Granted publication date: 20150610 Pledgee: Overpass Branch of Jinan Rural Commercial Bank Co.,Ltd. Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2023980032056 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230531 Granted publication date: 20150610 Pledgee: Overpass Branch of Jinan Rural Commercial Bank Co.,Ltd. Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2023980032056 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A highly efficient and stable TMB chromogenic solution and its preparation method Effective date of registration: 20230601 Granted publication date: 20150610 Pledgee: Overpass Branch of Jinan Rural Commercial Bank Co.,Ltd. Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2023980042636 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20150610 Pledgee: Overpass Branch of Jinan Rural Commercial Bank Co.,Ltd. Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2023980042636 |